Societe de Therapeutique Marocaine S.A.

SOT

MA0000012502

Pharmaceuticals

End-of-day quote Casablanca S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
1,010 ^MAD	0.00%		-0.10%	+6.20%

Apr. 19	Société de Therapeutique Marocaine S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Societe de Therapeutique Marocaine S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Societe de Therapeutique Marocaine S.A. agreed to acquire a 40% stake in Prodimedic

August 24, 2022

Societe de Therapeutique Marocaine S.A. (CBSE:SOT) agreed to acquire a 40% stake in Prodimedic on August 25, 2022.

Latest news about Societe de Therapeutique Marocaine S.A.

Société de Therapeutique Marocaine S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 18	CI
Societe de Therapeutique Marocaine S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-31	CI
Societe de Therapeutique Marocaine S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-21	CI
Societe de Therapeutique Marocaine S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-25	CI
Societe de Therapeutique Marocaine S.A. agreed to acquire a 40% stake in Prodimedic	22-08-24	CI
Societe de Therapeutique Marocaine S.A.(CBSE:SOT) added to S&P Pan Arab Composite	22-03-21	CI
Societe De Therapeutique Marocaine S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-30	CI
Societe de Therapeutique Marocaine S.A.(CBSE:SOT) added to MADEX Free Float Index	21-07-19	CI
Societe De Therapeutique Marocaine S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-29	CI
Societe de Therapeutique Marocaine - Sothema-S.A.'s Equity Buyback in the amount of MAD48.6 mm has expired	12-07-13	CI

Chart Societe de Therapeutique Marocaine S.A.

Duration

Period

Chart Societe de Therapeutique Marocaine S.A.

More charts

Sothema (Société de Thérapeutique Marocaine) is No. 1 in Morocco of manufacturing and marketing licensed pharmaceutical products and biotechnology drugs. The group's activity is organized around 3 areas: - drug sales: products made under license and under own names; - importing and sales of drugs, dental products, and ophthalmic equipment; - subcontractor fabrication of pharmaceutical products: services provided to Moroccan and foreign laboratories. At the end of 2019, Sothema had 6 production units located in Morocco.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

1,010

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SOCIETE DE THERAPEUTIQUE MAROCAINE S.A.	+6.20%	717M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals